Recall Z-1515-2022— Roche Diagnostics Operations, Inc.

Class II · Ongoing

Class II FDA medical device recall by Roche Diagnostics Operations, Inc., initiated 2022-07-14. FDA's recall record names no specific 510(k) clearance for this event. Product: cobas e801 Immunoassay Analyzer. Reason: Software issue resulting in signals and sample test results of Pre-Wash tests being impacted. The following assays are considered impacted by the issue: Anti-HAV2, Anti-HBc IgM, IGF-1, Myogloin, Rubella IgG, and Toxo IgG..

Recalling firm
Roche Diagnostics Operations, Inc.
Classification
Class II
Status
Ongoing
Initiated
2022-07-14
Firm location
Indianapolis, IN, United States

Product description

cobas e801 Immunoassay Analyzer

Reason for recall

Software issue resulting in signals and sample test results of Pre-Wash tests being impacted. The following assays are considered impacted by the issue: Anti-HAV2, Anti-HBc IgM, IGF-1, Myogloin, Rubella IgG, and Toxo IgG.

Data sourced from openFDA. This site is unofficial and independent of the FDA.